These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6952181)

  • 1. Affinity labeling of muscarinic receptors in rat cerebral cortex with a photolabile antagonist.
    Amitai G; Avissar S; Balderman D; Sokolovsky M
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):243-7. PubMed ID: 6952181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic antagonists induce different receptor conformations in rat adenohypophysis.
    Henis YI; Sokolovsky M
    Mol Pharmacol; 1983 Nov; 24(3):357-65. PubMed ID: 6633502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between antagonist-occupied muscarinic binding sites in rat adenohypophysis.
    Henis YI; Galron R; Avissar S; Sokolovsky M
    FEBS Lett; 1982 Apr; 140(2):173-6. PubMed ID: 7084461
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscarinic receptors of the pancreas: a correlation between displacement of (3 H)-quinuclidinyl benzilate binding and amylase secretion.
    Ng KH; Morisset J; Poirier GG
    Pharmacology; 1979; 18(5):263-70. PubMed ID: 482346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.
    Gibson RE; Eckelman WC; Vieras F; Reba RC
    J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisquaternary pyridinium oximes as allosteric inhibitors of rat brain muscarinic receptors.
    Kloog Y; Sokolovsky M
    Mol Pharmacol; 1985 Apr; 27(4):418-28. PubMed ID: 3884998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of muscarinic receptors in rat cerebral cortical microvessels.
    Grammas P; Diglio CA; Marks BH; Giacomelli F; Wiener J
    J Neurochem; 1983 Mar; 40(3):645-51. PubMed ID: 6827266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible and irreversible inhibition of rat brain muscarinic receptors is related to different substitutions on bisquaternary pyridinium oximes.
    Kloog Y; Galron R; Balderman D; Sokolovsky M
    Arch Toxicol; 1985 Oct; 58(1):37-9. PubMed ID: 3907590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states.
    Avissar S; Amitai G; Sokolovsky M
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):156-9. PubMed ID: 6571990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous binding of [3H]N-methyl-quinuclidinyl benzilate methyl chloride to human lymphocyte muscarinic receptors.
    Usami K; Kaku Y
    Life Sci; 1992; 51(8):PL67-71. PubMed ID: 1640803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two ligands may bind simultaneously to the muscarine receptor.
    Hedlund B; Grynfarb M; Bartfai T
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):3-13. PubMed ID: 6896905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 125I-labeled binding probe for the muscarinic cholinergic receptor.
    Flanagan SD; Storni A
    Brain Res; 1979 May; 168(2):261-74. PubMed ID: 445143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.